Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories
- 1 December 2016
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 15 (12) , 1161-1166
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Statin-Associated Autoimmune MyopathyNew England Journal of Medicine, 2016
- Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and ManagementCurrent Rheumatology Reports, 2015
- Statins and myositis: the role of anti-HMGCR antibodiesExpert Review of Clinical Immunology, 2015
- Inflammatory Muscle DiseasesNew England Journal of Medicine, 2015
- Statin‐associated autoimmune myopathy and anti‐HMGCR autoantibodiesMuscle & Nerve, 2013
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010
- 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The NetherlandsNeuromuscular Disorders, 2004
- Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology1989
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975